title: Endometrioid adenocarcinoma arising from endometriosis during 2 years of estrogen replacement therapy after total hysterectomy and bilateral salpingo-oophorectomy.
authors.affiliation: Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Nagoya, Japan. snomura@med.nagoya-u.ac.jp
authors.forename: Seiji
authors.initials: S
authors.lastname: Nomura
authors.forename: Takayasu
authors.initials: T
authors.lastname: Suganuma
authors.forename: Takahiro
authors.initials: T
authors.lastname: Suzuki
authors.forename: Tomomi
authors.initials: T
authors.lastname: Ito
authors.forename: Hiroaki
authors.initials: H
authors.lastname: Kajiyama
authors.forename: Mayumi
authors.initials: M
authors.lastname: Okada
authors.forename: Kiyosumi
authors.initials: K
authors.lastname: Shibata
authors.forename: Kazuhiko
authors.initials: K
authors.lastname: Ino
authors.forename: Fumitaka
authors.initials: F
authors.lastname: Kikkawa
authors.forename: Shigehiko
authors.initials: S
authors.lastname: Mizutani
mesh_terms: D000328:Adult; D018269:Carcinoma, Endometrioid / Q000209:etiology* / Q000556:secondary; D016889:Endometrial Neoplasms / Q000209:etiology* / Q000473:pathology; D004715:Endometriosis / Q000473:pathology / Q000628:therapy*; D015914:Estrogen Replacement Therapy / Q000009:adverse effects*; D017809:Fatal Outcome; D005260:Female; D006801:Humans; D007044:Hysterectomy; D010052:Ovariectomy; D014591:Uterine Diseases / Q000473:pathology / Q000628:therapy*